Payment overview · 2025
General Payments
$36.33
2 reported records · 2 companies
Healthcare provider profile · identity verified
Marien Perez, APRN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · MIAMI, FL · NPI 1902374762
Verified facts
What the public records show
CMS Open Payments records show Marien Perez, APRN received $36.33 in general payments during 2025 across 2 reported records.
Cipher Pharmaceuticals US LLC accounted for 57.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Cipher Pharmaceuticals US LLC | Unresolved — no canonical attribution shown | $20.73 | 57.1% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $15.60 | 42.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $36.33 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Natroba Normalized: natroba |
Drug | Cipher Pharmaceuticals US LLC | $20.73 | 1 | 2025 |
Source payment records
|
|||||
| Spinosad Normalized: spinosad |
Drug | Cipher Pharmaceuticals US LLC | $20.73 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15.60 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 524 | 59 |
| Atorvastatin Calcium | Atorvastatin Calcium | 507 | 96 |
| Amlodipine Besylate | Amlodipine Besylate | 336 | 64 |
| Losartan Potassium | Losartan Potassium | 328 | 58 |
| Levothyroxine Sodium | Levothyroxine Sodium | 321 | 48 |
| Gabapentin | Gabapentin | 297 | 49 |
| Pantoprazole Sodium | Pantoprazole Sodium | 296 | 52 |
| Metformin Hcl | Metformin Hcl | 295 | 52 |
| Tamsulosin Hcl | Tamsulosin Hcl | 266 | 46 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 263 | 43 |
| Metoprolol Tartrate | Metoprolol Tartrate | 241 | 49 |
| Lactulose | Lactulose | 238 | 37 |
| Lisinopril | Lisinopril | 233 | 34 |
| Trazodone Hcl | Trazodone Hcl | 227 | 40 |
| Montelukast Sodium | Montelukast Sodium | 196 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 186 | 38 |
| Furosemide | Furosemide | 178 | 35 |
| Famotidine | Famotidine | 176 | 38 |
| Omeprazole | Omeprazole | 159 | 36 |
| Levetiracetam | Levetiracetam | 157 | 30 |
| Escitalopram Oxalate | Escitalopram Oxalate | 154 | 32 |
| Latanoprost | Latanoprost | 136 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 135 | 28 |
| Metoprolol Succinate | Metoprolol Succinate | 135 | 31 |
| Quetiapine Fumarate | Quetiapine Fumarate | 133 | 30 |
| Sertraline Hcl | Sertraline Hcl | 133 | 26 |
| Carvedilol | Carvedilol | 132 | 26 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 122 | 20 |
| Donepezil Hcl | Donepezil Hcl | 121 | 19 |
| Potassium Chloride | Potassium Chloride | 111 | 25 |
| Mirtazapine | Mirtazapine | 109 | 29 |
| Brimonidine Tartrate | Brimonidine Tartrate | 107 | 12 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 106 | 43 |
| Allopurinol | Allopurinol | 102 | 15 |
| Mupirocin | Mupirocin | 98 | 43 |
| Memantine Hcl | Memantine Hcl | 95 | 16 |
| Nifedipine Er | Nifedipine | 94 | 22 |
| Fenofibrate | Fenofibrate Nanocrystallized | 93 | 14 |
| Ozempic | Semaglutide | 93 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 91 | 20 |
| Alendronate Sodium | Alendronate Sodium | 89 | 14 |
| Levofloxacin | Levofloxacin | 89 | 40 |
| Ammonium Lactate | Ammonium Lactate | 85 | 15 |
| Novolog Flexpen | Insulin Aspart | 84 | 19 |
| Linzess | Linaclotide | 83 | 17 |
| Ibuprofen | Ibuprofen | 82 | 19 |
| Nystatin | Nystatin | 81 | 31 |
| Warfarin Sodium | Warfarin Sodium | 81 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 76 | 22 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 72 | 17 |
| Silver Sulfadiazine | Silver Sulfadiazine | 70 | 19 |
| Clonidine Hcl | Clonidine Hcl | 69 | 20 |
| Dicyclomine Hcl | Dicyclomine Hcl | 68 | 13 |
| Mounjaro | Tirzepatide | 68 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 66 | 20 |
| Simvastatin | Simvastatin | 65 | 12 |
| Midodrine Hcl | Midodrine Hcl | 62 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 61 | 23 |
| Bumetanide | Bumetanide | 60 | 16 |
| Doxazosin Mesylate | Doxazosin Mesylate | 60 | suppressed |
| Ketoconazole | Ketoconazole | 59 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 58 | 13 |
| Benztropine Mesylate | Benztropine Mesylate | 57 | suppressed |
| Jardiance | Empagliflozin | 57 | suppressed |
| Januvia | Sitagliptin Phosphate | 56 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 55 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 55 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 55 | suppressed |
| Finasteride | Finasteride | 54 | suppressed |
| Meropenem | Meropenem | 54 | suppressed |
| Trulicity | Dulaglutide | 53 | suppressed |
| Risperidone | Risperidone | 52 | 13 |
| Sodium Chloride | 0.9 % Sodium Chloride | 52 | 22 |
| Alprazolam | Alprazolam | 51 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 51 | suppressed |
| Ingrezza | Valbenazine Tosylate | 51 | suppressed |
| Glipizide | Glipizide | 50 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 47 | suppressed |
| Baclofen | Baclofen | 46 | 12 |
| Procrit | Epoetin Alfa | 46 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 46 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 44 | suppressed |
| Enulose | Lactulose | 44 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 44 | suppressed |
| Sucralfate | Sucralfate | 44 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 42 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 42 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 42 | 11 |
| Ssd | Silver Sulfadiazine | 42 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 42 | 22 |
| Scopolamine | Scopolamine | 41 | suppressed |
| Xarelto | Rivaroxaban | 41 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 39 | suppressed |
| Vascepa | Icosapent Ethyl | 39 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 37 | 29 |
| Calcitriol | Calcitriol | 37 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 37 | suppressed |
| Cephalexin | Cephalexin | 36 | 18 |
| Divalproex Sodium | Divalproex Sodium | 35 | 14 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 34 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 34 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 33 | suppressed |
| Clonazepam | Clonazepam | 33 | suppressed |
| Lacosamide | Lacosamide | 33 | suppressed |
| Entresto | Sacubitril/Valsartan | 32 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 32 | suppressed |
| Gemtesa | Vibegron | 31 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 31 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 30 | 21 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 30 | 18 |
| Fetzima | Levomilnacipran Hcl | 29 | suppressed |
| Lorazepam | Lorazepam | 29 | suppressed |
| Azithromycin | Azithromycin | 28 | 19 |
| Naproxen | Naproxen | 28 | suppressed |
| Prednisone | Prednisone | 28 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 28 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 27 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 27 | suppressed |
| Meloxicam | Meloxicam | 27 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Tradjenta | Linagliptin | 27 | suppressed |
| Glimepiride | Glimepiride | 26 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 26 | 12 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 26 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 25 | suppressed |
| Timolol Maleate | Timolol Maleate | 25 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 24 | suppressed |
| Cyclosporine | Cyclosporine | 24 | suppressed |
| Hydrocortisone | Hydrocortisone | 24 | suppressed |
| Insulin Lispro | Insulin Lispro | 24 | suppressed |
| Metronidazole | Metronidazole | 24 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 24 | suppressed |
| Nystop | Nystatin | 24 | 11 |
| Gemfibrozil | Gemfibrozil | 23 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 23 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 23 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 22 | suppressed |
| Digoxin | Digoxin | 22 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 22 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl/Pf | 22 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 21 | 11 |
| Pregabalin | Pregabalin | 21 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 20 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 20 | suppressed |
| Nyamyc | Nystatin | 20 | suppressed |
| Bupropion Xl | Bupropion Hcl | 19 | suppressed |
| Calcium Acetate | Calcium Acetate | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 19 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 19 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 19 | suppressed |
| Glyburide | Glyburide | 19 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 19 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 19 | suppressed |
| Fluconazole | Fluconazole | 18 | 12 |
| Insulin Aspart Flexpen | Insulin Aspart | 18 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 18 | suppressed |
| Amantadine | Amantadine Hcl | 17 | suppressed |
| Bicalutamide | Bicalutamide | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 17 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 17 | suppressed |
| Mesalamine | Mesalamine | 17 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 17 | 12 |
| Theophylline Er | Theophylline Anhydrous | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Glipizide Er | Glipizide | 16 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 16 | suppressed |
| Repaglinide | Repaglinide | 16 | suppressed |
| Spironolactone | Spironolactone | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Ertapenem | Ertapenem Sodium | 15 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 15 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 14 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Imipenem-Cilastatin Sodium | Imipenem/Cilastatin Sodium | 14 | suppressed |
| Kerendia | Finerenone | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 14 | suppressed |
| Sodium Bicarbonate | Sodium Bicarbonate | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 13 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Admelog Solostar | Insulin Lispro | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Ciclopirox | Ciclopirox | 12 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Olanzapine | Olanzapine | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 11 | suppressed |
| Levofloxacin-D5w | Levofloxacin In Dextrose 5 % | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Sodium Chloride | Sodium Chloride 0.45 % | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $36.33 · 2 records | Cipher Pharmaceuticals US LLC | CAPLYTA, Natroba, Spinosad | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error